Ceftriaxone 2 g IV Duration and Dosing for Central Nervous System Infections

Meningococcal Disease (5‑day Course Acceptable)

• In patients with confirmed meningococcal meningitis, ceftriaxone 2 g IV every 12 h may be stopped after 5 days if clinical recovery (e.g., afebrile, stable neurologic status) is documented. 1
• The same 5‑day regimen is appropriate for confirmed meningococcal sepsis when the patient has recovered by day 5. 3
• For probable meningococcal disease (typical petechial/purpuric rash without pathogen identification) that has clinically resolved by day 5, treatment can also be discontinued. 3

Pneumococcal Meningitis (Longer Course Required)

• Ceftriaxone 2 g IV every 12 h should be continued for a minimum of 10 days in pneumococcal meningitis when the patient is clinically stable. 1
• If the patient has not recovered by day 10, the course should be extended to 14 days. 1
• For pneumococcal strains resistant to penicillin or cephalosporins, a mandatory 14‑day treatment duration is recommended regardless of clinical response. 1

Other Serious CNS Infections

• Haemophilus influenzae meningitis requires 10 days of ceftriaxone 2 g IV every 12 h. 3
• Listeria monocytogenes CNS infection requires 21 days of therapy (preferred agent is amoxicillin, not ceftriaxone). 3
• Enterobacteriaceae CNS infections also mandate 21 days of ceftriaxone therapy. 3
• When the causative pathogen is unidentified but the patient has clinically recovered, empiric therapy may be stopped at day 10. 3

Dosing Frequency for CNS Infections

• For meningitis, ceftriaxone 2 g every 12 hours is recommended over once‑daily dosing to ensure adequate cerebrospinal fluid penetration. 1
• Established infection guidelines consistently endorse the twice‑daily regimen for adult patients. 1

Critical Pitfalls to Avoid

• A 5‑day ceftriaxone course is inadequate for pneumococcal meningitis; a minimum of 10 days is required. 1
• In meningitis with an unknown pathogen, therapy should be continued until day 10 unless meningococcal disease is confirmed. 3
• Even in confirmed meningococcal disease, if fever or neurologic symptoms persist beyond day 5, the treatment duration must be extended. 1
• Blood and CSF cultures should be obtained before initiating antibiotics whenever feasible. 1

Practical Algorithm for Ceftriaxone Use in CNS Infections

• Identify the pathogen (or most likely organism based on presentation). 3
• If meningococcal disease is confirmed or highly suspected:
• If pneumococcal meningitis:
• If the pathogen is unknown: